IN8bio Inc (INAB)
0.8383
-0.06
(-6.78%)
USD |
NASDAQ |
Jun 28, 16:00
0.8383
0.00 (0.00%)
After-Hours: 20:00
IN8bio Cash from Financing (Quarterly): -0.277M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.277M |
| December 31, 2023 | 13.35M |
| September 30, 2023 | 1.652M |
| June 30, 2023 | 11.49M |
| March 31, 2023 | 0.547M |
| December 31, 2022 | -0.253M |
| September 30, 2022 | 9.41M |
| June 30, 2022 | -0.067M |
| March 31, 2022 | -0.102M |
| Date | Value |
|---|---|
| December 31, 2021 | -1.212M |
| September 30, 2021 | 35.19M |
| June 30, 2021 | -0.592M |
| March 31, 2021 | -0.435M |
| December 31, 2020 | -0.949M |
| September 30, 2020 | 19.61M |
| June 30, 2020 | 0.174M |
| March 31, 2020 | 5.68M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-1.212M
Minimum
Dec 2021
35.19M
Maximum
Sep 2021
5.484M
Average
0.174M
Median
Jun 2020
Cash from Financing (Quarterly) Benchmarks
| Jaguar Health Inc | 12.27M |
| Aptevo Therapeutics Inc | -0.003M |
| NovaBay Pharmaceuticals Inc | -0.597M |
| Palatin Technologies Inc | 9.136M |
| iBio Inc | 5.025M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -7.919M |
| Cash from Investing (Quarterly) | -0.071M |
| Free Cash Flow | -24.06M |
| Free Cash Flow Per Share (Quarterly) | -0.1846 |
| Free Cash Flow Yield | -83.23% |